Page last updated: 2024-08-16

ribavirin and Angioimmunoblastic Lymphadenopathy

ribavirin has been researched along with Angioimmunoblastic Lymphadenopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dickinson, GM; Heseltine, PN; Johnson, KM; Leedom, JM; Lubina, JA; Makuch, RW; Mansell, PW; Roberts, RB; Rodriguez, S1

Trials

1 trial(s) available for ribavirin and Angioimmunoblastic Lymphadenopathy

ArticleYear
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.
    Journal of acquired immune deficiency syndromes, 1990, Volume: 3, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; CD4 Antigens; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Double-Blind Method; Evaluation Studies as Topic; Humans; Immunoblastic Lymphadenopathy; Leukocyte Count; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ribavirin; Ribonucleosides

1990